Gilead Nears Offer to Get Immunomedics for Greater Than $20 Billion

0
1
Loading ....

Gilead Sciences Inc. is nearing a bargain to purchase biotech Immunomedics Inc. as well as its treasured breast-cancer medication for greater than $20 billion, according to individuals aware of the issue.
Immunomedics has a …
Read More

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here